New Hampshire-based Vapotherm – a maker of advanced respiratory care devices – just raised what looks like a $20 million Series C round, according to a regulatory filing.
The company builds breathing tubes for patients with respiratory issues – from neonatal to geriatric. They’re meant for patients with conditions like asthma, COPD, bronochiolitis and congestive heart failure. It holds a robust international patent portfolio for hospital and home care breathing tubes – heating and humidifying breathing gases.
Last year, Vapotherm closed out a $24 million Series B, led by Gilde Healthcare Partners, but with new investor Adage Capital Management and existing investors 3×5
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Calls to Vapotherm about this new funding round have yet to be returned.
